Stock-Based Compensation (Tables)

12 Months Ended

Dec. 29, 2020

Share-based Payment Arrangement [Abstract]

Schedule of Weighted-Average Valuation Assumptions

The weighted-average assumptions used in the model were as follows:

	2019			2018
Risk-free interest rate	1.8		%	2.7		%
Expected term (average in years)	6.2			6.2
Expected dividend yield	—			—
Expected volatility	55.7		%	51.0		%
Weighted-average Black-Scholes fair value per share at date of grant	$	4.16		$	5.11

Schedule of Option Award Activity

A summary of aggregate option award activity under the Plan as of December 29, 2020, and changes during the fiscal year then ended is presented below:

	Awards	Weighted- Average Exercise Price		Weighted-Average Remaining Contractual Term	Aggregate Intrinsic Value (1) (in thousands)
Outstanding—December 31, 2019	1,212,071	$	11.67
Granted	—	—
Forfeited or expired	(261,919)	8.69
Exercised	(10,799)	5.82
Outstanding—December 29, 2020	939,353	$	12.57	5.21	$	539
Vested and expected to vest	917,745	$	12.68	5.13	$	528
Exercisable as of December 29, 2020	753,883	$	13.77	4.52	$	364

_____________

(1)Aggregate intrinsic value represents the amount by which fair value of the Company’s stock exceeds the exercise price of the option as of December 29, 2020.

Schedule of Non-vested Restricted Share Units

A summary of the status of the Company’s non-vested restricted share units as of December 29, 2020 and changes during the year then ended is presented below:

	Awards	Weighted- Average Grant Date Fair Value
Outstanding—January 1, 2020	742,581	$	7.60
Granted	886,227	5.77
Vested	(268,807)	7.45
Forfeited	(204,675)	7.27
Non-vested at December 29, 2020	1,155,326	$	6.29